China National Accord Medicines Corporation Ltd. reported earnings results for the first quarter ended March 31, 2015. For the period, the company reported operating income of RMB 6,261,714,700.23, net profit attributable to shareholders of the listed company of RMB 197,026,237.82, net cash flow arising from operating activities of RMB 182,179,606.70 or RMB 0.543 per basic and diluted share against operating income of RMB 5,533,524,159.08, net profit attributable to shareholders of the listed company of RMB 167,818,387.39, net cash flow used in operating activities of RMB 425,683,165.96 or RMB 0.582 per basic and diluted share a year ago.